F
Francesco Mauri
Researcher at Imperial College London
Publications - 146
Citations - 7888
Francesco Mauri is an academic researcher from Imperial College London. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 45, co-authored 142 publications receiving 7085 citations. Previous affiliations of Francesco Mauri include Wakayama Medical University & Imperial College Healthcare.
Papers
More filters
Journal ArticleDOI
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Helena Furberg,Yunjung Kim,Jennifer Dackor,Eric Boerwinkle,Nora Franceschini,Diego Ardissino,Luisa Bernardinelli,Luisa Bernardinelli,Pier Mannuccio Mannucci,Francesco Mauri,Piera Angelica Merlini,Devin Absher,Themistocles L. Assimes,Stephen P. Fortmann,Carlos Iribarren,Joshua W. Knowles,Thomas Quertermous,Luigi Ferrucci,Toshiko Tanaka,Joshua C. Bis,Curt D. Furberg,Talin Haritunians,Barbara McKnight,Bruce M. Psaty,Bruce M. Psaty,Kent D. Taylor,Evan L. Thacker,Peter Almgren,Leif Groop,Claes Ladenvall,Michael Boehnke,Anne U. Jackson,Karen L. Mohlke,Heather M. Stringham,Jaakko Tuomilehto,Jaakko Tuomilehto,Emelia J. Benjamin,Shih-Jen Hwang,Daniel Levy,Sarah R. Preis,Ramachandran S. Vasan,Jubao Duan,Pablo V. Gejman,Douglas F. Levinson,Alan R. Sanders,Jianxin Shi,Esther H. Lips,James McKay,Antonio Agudo,Luigi Barzan,Vladimir Bencko,Simone Benhamou,Simone Benhamou,Xavier Castellsagué,Cristina Canova,David I. Conway,Eleonora Fabianova,Lenka Foretova,Vladimir Janout,Claire M. Healy,Ivana Holcatova,Kristina Kjærheim,Pagona Lagiou,Jolanta Lissowska,Ray Lowry,Tatiana V. Macfarlane,Dana Mates,Lorenzo Richiardi,Peter Rudnai,Neonilia Szeszenia-Dabrowska,David Zaridze,Ariana Znaor,Mark Lathrop,Paul Brennan,Stefania Bandinelli,Timothy M. Frayling,Jack M. Guralnik,Yuri Milaneschi,John R. B. Perry,David Altshuler,David Altshuler,Roberto Elosua,S. Kathiresan,S. Kathiresan,Gavin Lucas,Olle Melander,Christopher J. O'Donnell,Veikko Salomaa,Stephen M. Schwartz,Benjamin F. Voight,Brenda W.J.H. Penninx,Johannes H. Smit,Nicole Vogelzangs,Dorret I. Boomsma,Eco J. C. de Geus,Jacqueline M. Vink,Gonneke Willemsen,Stephen J. Chanock,Fangyi Gu,Susan E. Hankinson,David J. Hunter,Albert Hofman,Henning Tiemeier,André G. Uitterlinden,Cornelia M. van Duijn,Stefan Walter,Daniel I. Chasman,Brendan M. Everett,Guillaume Paré,Paul M. Ridker,Ming D. Li,Hermine H. Maes,Janet Audrain-McGovern,Danielle Posthuma,Laura M. Thornton,Caryn Lerman,Jaakko Kaprio,Jaakko Kaprio,Jed E. Rose,John P. A. Ioannidis,John P. A. Ioannidis,Peter Kraft,Danyu Lin,Patrick F. Sullivan +123 more
TL;DR: A meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium found the strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3, and three loci associated with number of cigarettes smoked per day were identified.
Journal ArticleDOI
Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis
Aldo A. Maggioni,Attilio Maseri,Claudio Fresco,Maria Grazia Franzosi,Francesco Mauri,Eugenio Santoro,Gianni Tognoni +6 more
TL;DR: The in-hospital mortality rate was 1.9 percent among patients 40 years old or younger, but it increased to 31.9% among those more than 80 years old; however, values for indicators of infarct size did not increase with age.
Journal ArticleDOI
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
Mattia Barbareschi,Patrick Maisonneuve,D. Aldovini,Maria Giulia Cangi,Lorenza Pecciarini,Francesco Mauri,Silvio Veronese,Orazio Caffo,A. Lucenti,Paolo Dalla Palma,Enzo Galligioni,Claudio Doglioni +11 more
TL;DR: Syndecan‐1 is a transmembrane heparan sulphate proteoglycan that is involved in cell–cell adhesion, organization of cell–matrixAdhesion, and regulation of growth factor signaling.
Journal ArticleDOI
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
E. Leonardi,Salvatore Girlando,Gabriella Serio,Francesco Mauri,G. Perrone,Scampini S,P. Dalla Palma,Mattia Barbareschi +7 more
TL;DR: The PCNA-LI does not seem to be a substitute for the Ki67-LI in evaluating the growth fraction in breast cancer, and its associations with other biological and clinicopathological variables are unknown.
Journal Article
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Giovanni Gasparini,Mattia Barbareschi,Claudio Doglioni,Paolo Dalla Palma,Francesco Mauri,Patrizia Boracchi,P. Bevilacqua,Orazio Caffo,Luca Morelli,Paolo Verderio +9 more
TL;DR: It is suggested that expression of bcl-2 protein and the number of metastatic lymph nodes are independent features predictive of clinical outcome in patients with node-positive breast cancer, irrespective of the type of adjuvant treatment.